Are serum biomarkers useful in the management of systemic sclerosis-associated interstitial lung disease?
Journal: 2021/February - Respirology
Abstract:
Keywords: biomarker; disease progression; interstitial lung disease, systemic sclerosis.
Relations:
Diseases
(2)
Conditions
(1)
Chemicals
(1)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.